Chest Wall Radiotherapy: Middle Ground for Treatment of Patients With One to Three Positive Lymph Nodes After Mastectomy-Reference-Cited by-同舟云学术

Chest Wall Radiotherapy: Middle Ground for Treatment of Patients With One to Three Positive Lymph Nodes After Mastectomy

Published:2009-12 Issue:5 Volume:75 Page:1297-1303
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

MacDonald Shannon M.,Abi-Raad Rita F.,Alm El-Din Mohamed A.,Niemierko Andrzej,Kobayashi Wendy,McGrath John J.,Goldberg Saveli I.,Powell Simon,Smith Barbara,Taghian Alphonse G.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial;Overgaard;Lancet,1999

2. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial;Ragaz;J Natl Cancer Inst,2005

3. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial;Overgaard;N Engl J Med,1997

4. Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link;Van de Steene;Radiother Oncol,2000

5. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials;Lancet,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Dosimetry: IMRT versus 3DCRT in Left-Sided Breast Cancer Patients with Considering Some Organs in Out - of – Field Borders;Breast Cancer: Targets and Therapy;2024-09

2. The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis;Cancers;2023-11-19

3. A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer;Cancer;2022-06-17

4. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?;Breast Cancer Research and Treatment;2021-09-06

5. Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy;Radiation Oncology;2020-09-04